Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
18,647,649
-
Share change
-
-1,783,738
-
Total reported value
-
$14,941,801
-
Price per share
-
$0.80
-
Number of holders
-
22
-
Value change
-
-$1,890,275
-
Number of buys
-
8
-
Number of sells
-
10
Institutional Holders of BELLEROPHON THERAPEUTICS INC - COM (BLPH) as of Q4 2018
As of 31 Dec 2018,
BELLEROPHON THERAPEUTICS INC - COM (BLPH) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,647,649 shares.
The largest 10 holders included
Puissance Capital Management LP, VHCP Management II, LLC, VHCP Management III, LLC, RENAISSANCE TECHNOLOGIES LLC, ARCH VENTURE CORP, Vanguard Group Inc, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, Bank of New York Mellon Corp, and LPL Financial LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.